OptimizeRx Corp Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
OptimizeRx Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • OptimizeRx Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.75M, a 22.7% increase year-over-year.
  • OptimizeRx Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$23.3M, a 40.7% decline year-over-year.
  • OptimizeRx Corp annual Operating Income (Loss) for 2023 was -$26.4M, a 115% decline from 2022.
  • OptimizeRx Corp annual Operating Income (Loss) for 2022 was -$12.3M, a 3504% decline from 2021.
  • OptimizeRx Corp annual Operating Income (Loss) for 2021 was $361K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$26.4M -$14.1M -115% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 -$12.3M -$12.7M -3504% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $361K +$2.5M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$2.14M +$1.56M +42.2% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
2019 -$3.69M -$3.87M -2150% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $180K +$2.31M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$2.13M -$548K -34.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$1.58M -$984K -165% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 -$597K +$429K +41.8% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 -$1.03M -$759K -284% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 -$268K +$187K +41.2% Jan 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
2012 -$455K +$999K +68.7% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$1.45M +$392K +21.2% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-12
2010 -$1.85M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.